🇺🇸 FDA
Patent

US 9394541

Oral delivery of nucleic acid-based gene interfering agents by Salmonella

granted A61KA61K35/74A61K48/00

Quick answer

US patent 9394541 (Oral delivery of nucleic acid-based gene interfering agents by Salmonella) held by The Regents of the University of California expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/74, A61K48/00